ISSN: 2155-9554
+44 1478 350008
Postinflammatory hyperpigmentation (PIH) is a reactive hypermelanosis that develops following cutaneous inflammation. Hyperpigmentation may be localized, as in the case of post-inflammatory hyperpigmentation or melasma, or more diffuse in its presentation. Common causes of PIH include intrinsic skin conditions (e.g., acne and eczema) as well as external insults to the skin, such as burn injuries and dermatologic procedures. PIH more commonly occurs in individuals with darker skin, for whom it is often a source of significant psychological distress. Several therapeutic modalities are available for the treatment of PIH, including topical agents, chemical peels, and energy-based devices. We review the epidemiology, clinical presentation, pathogenesis, and treatment of PIH.
Research Article: Journal of Clinical & Experimental Dermatology Research
Research Article: Journal of Clinical & Experimental Dermatology Research
Letter to Editor: Journal of Clinical & Experimental Dermatology Research
Research Article: Journal of Clinical & Experimental Dermatology Research
Research Article: Journal of Clinical & Experimental Dermatology Research
Scientific Tracks Abstracts: Journal of Clinical and Cellular Immunology
Posters & Accepted Abstracts: Journal of Clinical Toxicology
Posters & Accepted Abstracts: Journal of Clinical and Experimental Ophthalmology
ScientificTracks Abstracts-Workshop: Journal of Clinical & Experimental Dermatology Research
Scientific Tracks Abstracts: Journal of Clinical & Experimental Dermatology Research